Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea
· Delayed Price · Currency is KRW 6,340.00
-250.00 (-3.79%)
At close: Mar 31, 2025, 3:30 PM KST
Ahn-Gook Pharmaceutical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 271,116 | 233,676 | 205,389 | 163,534 | 143,364 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | Upgrade
|
| Revenue | 271,116 | 233,676 | 205,389 | 163,534 | 143,364 | Upgrade
|
| Revenue Growth (YoY) | 16.02% | 13.77% | 25.59% | 14.07% | -8.01% | Upgrade
|
| Cost of Revenue | 103,219 | 93,105 | 79,109 | 62,516 | 58,471 | Upgrade
|
| Gross Profit | 167,896 | 140,571 | 126,279 | 101,018 | 84,893 | Upgrade
|
| Selling, General & Admin | 145,430 | 121,343 | 102,052 | 83,157 | 64,021 | Upgrade
|
| Research & Development | 13,259 | 12,255 | 12,957 | 17,328 | 16,993 | Upgrade
|
| Operating Expenses | 161,219 | 135,509 | 116,899 | 102,102 | 84,942 | Upgrade
|
| Operating Income | 6,678 | 5,061 | 9,381 | -1,084 | -49.1 | Upgrade
|
| Interest Expense | -3,002 | -142.75 | -160.41 | -116.83 | -756.89 | Upgrade
|
| Interest & Investment Income | 463.68 | 388.54 | 407.43 | 335.82 | 971.68 | Upgrade
|
| Earnings From Equity Investments | 1,352 | -1,641 | -1,645 | 2,613 | 1,780 | Upgrade
|
| Currency Exchange Gain (Loss) | 68.82 | -79.74 | -82.27 | 133.07 | -302.34 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,453 | -258.15 | 336.26 | -246.68 | -1,431 | Upgrade
|
| EBT Excluding Unusual Items | 7,013 | 3,328 | 8,237 | 1,634 | 212.8 | Upgrade
|
| Gain (Loss) on Sale of Investments | 230.47 | 921.68 | -889.55 | 2,033 | 625.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | 13,216 | 17.13 | 28.25 | 138.65 | -60.42 | Upgrade
|
| Asset Writedown | -219.98 | - | - | - | - | Upgrade
|
| Pretax Income | 20,239 | 4,267 | 7,375 | 3,805 | 778.08 | Upgrade
|
| Income Tax Expense | 3,896 | 3,269 | 496.14 | 61.49 | 2,166 | Upgrade
|
| Earnings From Continuing Operations | 16,343 | 998.28 | 6,879 | 3,744 | -1,388 | Upgrade
|
| Net Income to Company | 16,343 | 998.28 | 6,879 | 3,744 | -1,388 | Upgrade
|
| Minority Interest in Earnings | 502.28 | 291.85 | -3.95 | 195.56 | 72.98 | Upgrade
|
| Net Income | 16,845 | 1,290 | 6,875 | 3,939 | -1,315 | Upgrade
|
| Net Income to Common | 16,845 | 1,290 | 6,875 | 3,939 | -1,315 | Upgrade
|
| Net Income Growth | 1205.72% | -81.24% | 74.54% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 13 | Upgrade
|
| Shares Change (YoY) | 0.44% | -0.55% | -0.65% | -9.44% | 10.37% | Upgrade
|
| EPS (Basic) | 1482.00 | 114.00 | 604.21 | 343.93 | -114.79 | Upgrade
|
| EPS (Diluted) | 1482.00 | 114.00 | 604.00 | 343.93 | -114.79 | Upgrade
|
| EPS Growth | 1200.00% | -81.13% | 75.62% | - | - | Upgrade
|
| Free Cash Flow | -70,972 | -6,802 | -1,143 | -2,563 | -12,929 | Upgrade
|
| Free Cash Flow Per Share | -6243.89 | -601.03 | -100.42 | -223.77 | -1022.23 | Upgrade
|
| Gross Margin | 61.93% | 60.16% | 61.48% | 61.77% | 59.21% | Upgrade
|
| Operating Margin | 2.46% | 2.17% | 4.57% | -0.66% | -0.03% | Upgrade
|
| Profit Margin | 6.21% | 0.55% | 3.35% | 2.41% | -0.92% | Upgrade
|
| Free Cash Flow Margin | -26.18% | -2.91% | -0.56% | -1.57% | -9.02% | Upgrade
|
| EBITDA | 14,376 | 10,084 | 14,311 | 3,423 | 4,634 | Upgrade
|
| EBITDA Margin | 5.30% | 4.32% | 6.97% | 2.09% | 3.23% | Upgrade
|
| D&A For EBITDA | 7,698 | 5,023 | 4,930 | 4,507 | 4,683 | Upgrade
|
| EBIT | 6,678 | 5,061 | 9,381 | -1,084 | -49.1 | Upgrade
|
| EBIT Margin | 2.46% | 2.17% | 4.57% | -0.66% | -0.03% | Upgrade
|
| Effective Tax Rate | 19.25% | 76.61% | 6.73% | 1.62% | 278.43% | Upgrade
|
| Advertising Expenses | 11,337 | 5,543 | 5,776 | 5,482 | 3,935 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.